Mochida Pharmaceutical Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	9,164	8,052	6,160	9,044	14,591	11,900
Depreciation & Amortization	2,943	2,940	2,808	2,672	2,689	2,742
Loss (Gain) From Sale of Assets	3	14	-22	53	112	107
Loss (Gain) From Sale of Investments	-	-	-100	-	-526	-
Loss (Gain) on Equity Investments	583	618	168	-	-	-
Other Operating Activities	-1,962	-951	-1,366	-4,172	-5,709	-2,121
Change in Accounts Receivable	-3,136	3,220	-7,032	3,869	-2,486	-740
Change in Inventory	-3,086	-3,016	-5,873	-1,277	-521	2,466
Change in Accounts Payable	1,158	-3,522	2,225	-1,941	2,176	-3,934
Change in Other Net Operating Assets	-788	1,999	-4,448	-951	-2,867	-1,222
Operating Cash Flow	4,879	9,354	-7,480	7,297	7,459	9,198
Operating Cash Flow Growth	-29.99%	-	-	-2.17%	-18.91%	-1.59%
Capital Expenditures	-2,071	-2,160	-2,296	-2,166	-2,988	-1,935
Sale of Property, Plant & Equipment	3	2	56	-	-	204
Investment in Securities	11,700	19,500	2,301	-1,100	1,098	1,000
Other Investing Activities	14	13	13	317	-117	-149
Investing Cash Flow	9,646	17,355	74	-2,949	-2,007	-880
Repurchase of Common Stock	-2	-3	-3,492	-3,512	-2,511	-2,008
Common Dividends Paid	-2,835	-2,835	-2,887	-3,372	-3,445	-3,103
Other Financing Activities	-27	-27	-14	-	-	-1
Financing Cash Flow	-2,864	-2,865	-6,393	-6,884	-5,956	-5,112
Foreign Exchange Rate Adjustments	65	16	79	32	31	-9
Miscellaneous Cash Flow Adjustments	-	-	-	-	1	-2
Net Cash Flow	11,726	23,860	-13,720	-2,504	-472	3,195
Free Cash Flow	2,808	7,194	-9,776	5,131	4,471	7,263
Free Cash Flow Growth	-46.48%	-	-	14.76%	-38.44%	-1.70%
Free Cash Flow Margin	2.57%	6.84%	-9.50%	4.97%	4.06%	7.05%
Free Cash Flow Per Share	79.21	202.93	-272.59	138.08	117.34	188.00
Cash Interest Paid	18	18	37	35	36	36
Cash Income Tax Paid	1,954	948	1,368	3,224	3,616	2,154
Levered Free Cash Flow	1,617	6,041	-10,050	5,890	5,615	8,755
Unlevered Free Cash Flow	1,619	6,042	-10,049	5,890	5,615	8,755
Change in Working Capital	-5,852	-1,319	-15,128	-300	-3,698	-3,430

Source: S&P Global Market Intelligence. Standard template. Financial Sources.